Lennart Ahnfelt

Prognosis of total hip replacement in Sweden: Follow-up of 92,675 operations performed 1978–1990

Henrik Malchau, Peter Herberts, Lennart Ahnfelt · Acta Orthopaedica Scandinavica · 1993 · 602 citations

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Bengt I. Eriksson, O.E. Dahl, Harry R. Büller et al. · Journal of Thrombosis and Haemostasis · 2004 · 412 citations

Thrombopoiesis, Thrombosis, Dabigatran Etexilate +11

Prognosis of total hip replacement

Lennart Ahnfelt, Peter Herberts, Henrik Malchau et al. · Acta Orthopaedica Scandinavica · 1990 · 298 citations · Full text

Hip Arthroplasty, Total Hip Replacement, Osteoarthritis +8

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Joachim Stangier, Bengt I. Eriksson, Ola E. Dahl et al. · The Journal of Clinical Pharmacology · 2005 · 290 citations

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

Bengt I. Eriksson, O.E. Dahl, Lennart Ahnfelt et al. · Journal of Thrombosis and Haemostasis · 2004 · 202 citations · Full text

Thrombosis, Dabigatran Etexilate, Hematology +6